Galileo Life Sciences (MDRM) 10-Q 11 Jul 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Dec. 31, 2013	Jul. 09, 2014
Document And Entity Information	'	'
Entity Registrant Name	'Modern Mobility Aids, Inc.	'
Entity Central Index Key	'0001497165	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'true	'
Current Fiscal Year End Date	'--06-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	75,480,000
Amendment Description	'true	'
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Jun. 30, 2013
Current Assets:	'	'
Total Assets	$0	$0
Current Liabilities:	'	'
Accounts payable and accrued liabilities	171,189	140,027
Due to related parties	25,171	19,179
Loan from shareholders	363,275	360,567
Total current liabilities	559,635	519,773
Total Liabilities	559,635	519,773
Stockholders' Deficit:	'	'
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized issued and outstanding	'	'
Common stock, par value $0.001 per share, 200,000,000 shares authorized; 75,480,000 shares issued and outstanding	75,480	195,480
Additional paid in capital	-10,213	-130,213
(Deficit) accumulated during the development stage	-624,902	-585,040
Total stockholders' deficit	-559,635	-519,773
Total Liabilities and Stockholders'Deficit	$0	$0

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Statement of Financial Position [Abstract]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	75,480,000	195,480,000
Common stock, shares outstanding	75,480,000	195,480,000
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended		72 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Income Statement [Abstract]	'	'	'	'	'
Revenues, net	'	'	'	'	$9,506
Cost of Revenues	'	'	'	'	6,096
Gross Profit	'	'	'	'	3,410
Operating Expenses:	'	'	'	'	'
Accounting and audit fees	9,436	5,950	14,936	5,950	53,636
Bank charges	40	'	84	'	586
Officer compensation	'	'	'	'	6,920
Other and deposit	19	'	357	'	63,614
Consulting	13,838	658	15,213	658	283,195
Legal	6,544	'	6,544	'	137,726
Legal - Organization costs	'	'	'	'	38,980
Transfer agent	1,650	2,242	3,400	2,242	46,941
Total operating expenses	31,527	8,850	40,534	8,850	631,598
(Loss) from Operations	-31,527	-8,850	-40,534	-8,850	-628,188
Other Income (Expense)	2,440	'	672	'	3,286
(Loss) before Income Taxes	-29,087	-8,850	-39,862	-8,850	-624,902
Provision for Income Taxes	'	'	'	'	'
Net (Loss)	($29,087)	($8,850)	($39,862)	($8,850)	($624,902)
(Loss) Per Common Share - Basic and Diluted	$0	$0	$0	$0	'
Weighted Average Number of Common Shares Outstanding- Basic and Diluted	144,610,435	195,480,000	170,045,217	195,480,000	'

CONSOLIDATED_STATEMENT_OF_MOVE

CONSOLIDATED STATEMENT OF MOVEMENT IN STOCKHOLDERS' DEFICIT (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Deficit Accumulated During the Development Stage [Member]	Total
Beginning balance at Dec. 18, 2007	'	'	'	'
Net loss	'	'	($1,106)	($1,106)
Balance at Jun. 30, 2008	'	'	-1,106	-1,106
Net loss	'	'	-661	-661
Balance at Jun. 30, 2009	'	'	-1,767	-1,767
Issuance of common stock, shares	130,000,000	'	'	'
Issuance of common stock	130,000	-123,500	'	6,500
Net loss	'	'	-8,777	-8,777
Balance at Jun. 30, 2010	130,000	-123,500	-10,544	-4,044
Balance, shares at Jun. 30, 2010	130,000,000	'	'	'
Contribution from a related party	'	17,842	'	17,842
Issuance of common stock, shares	65,480,000	'	'	'
Issuance of common stock	65,480	-24,555	'	40,925
Net loss	'	'	-158,275	-158,275
Balance at Jun. 30, 2011	195,480	-130,213	-168,819	-103,552
Balance, shares at Jun. 30, 2011	195,480,000	'	'	'
Net loss	'	'	-363,619	-363,619
Balance at Jun. 30, 2012	195,480	-130,213	-532,438	-467,171
Balance, shares at Jun. 30, 2012	195,480,000	'	'	'
Net loss	'	'	-52,602	-52,602
Balance at Jun. 30, 2013	195,480	-130,213	-585,040	-519,773
Beginning balance, shares at Jun. 30, 2013	195,480,000	'	'	'
Cancellation of common stock, shares	-120,000,000	'	'	'
Cancellation of common stock	-120,000	120,000	'	'
Net loss	'	'	-39,862	-39,862
Balance at Dec. 31, 2013	$75,480	($10,213)	($624,902)	($559,635)
Balance, shares at Dec. 31, 2013	75,480,000	'	'	'

CONSOLIDATED_STATEMENT_OF_MOVE1

CONSOLIDATED STATEMENT OF MOVEMENT IN STOCKHOLDERS' DEFICIT (Parenthetical) (USD $)	Jun. 30, 2011	Jun. 30, 2010
Statement of Stockholders' Equity [Abstract]	'	'
Common stock issued for cash, per share	$0.00	$0.00

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (USD $)	6 Months Ended		72 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Operating Activities:	'	'	'
Net (loss)	($39,862)	($8,850)	($624,902)
Changes in Current Assets and Liabilities-	'	'	'
Accounts payable and accrued liabilities	31,162	-19,295	171,189
Net Cash (Used in) Operating Activities	-8,700	-28,145	-453,713
Investing Activities:	'	'	'
Net Cash Provided by (Used in) Investing Activities	'	'	'
Financing Activities:	'	'	'
Contributions from related party	'	'	17,842
Proceeds from issuance of common stock	'	28,145	47,425
Loan from shareholders	2,708	'	363,275
Due to related parties	5,992	'	25,171
Net Cash Provided by Financing Activities	8,700	28,145	453,713
Net Increase (decrease) in Cash	'	'	'
Cash - Beginning of Period	'	'	'
Cash - End of Period	'	'	'
Supplemental Disclosure of Cash Flow Information:	'	'	'
Interest	'	'	'
Income taxes	'	'	'

Nature_of_Operations_and_Summa

Nature of Operations and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Nature of Operations and Summary of Significant Accounting Policies	'
	1. Summary of Significant Accounting Policies
	Basis of Presentation and Organization
	Modern Mobility Aids, Inc. (the “Company,” “we,” “us” or “our”) is a Nevada corporation in the development stage. The Company was incorporated under the laws of the State of Nevada on December 19, 2007 (“Inception”) under the name Glider Inc. with a business plan to sell and distribute products for mobility challenged individuals. The Company changed its name to Modern Mobility Aids, Inc. on April 22, 2010 with an initial plan to distribute products for mobility challenged individuals.
	The Company has abandoned its historic business of distributing products for mobility challenged individuals which has generated little operating revenue and has had limited operations to date and is now focused on exploiting the dynamic opportunities presented in the medical marijuana arena by the regulatory reforms rolled out in Canada. We plan to acquire or invest in multiple licensed producers in Canada and the U.S. The Company will require financing to make such acquisitions. There can be no assurance it can secure such financing or that it will be able to make such acquisitions even if financing is available. Moreover, even if it acquires business assets or a business, there can be no assurance that the acquisitions will be successfully accomplished and that our operations thereafter will be profitable.
	Unaudited Financial Statements
	The accompanying unaudited financial statements of the Company have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion the financial statements include all adjustments (consisting of normal recurring accruals) necessary in order to make the financial statements not misleading. Operating results for the three and six month periods ended December 31, 2013 are not necessarily indicative of the results that may be expected for the year ended June 30, 2014. For more complete financial information, these unaudited financial statements should be read in conjunction with the audited financial statements for the year ended June 30, 2013 included in our Form 10-K filed with the SEC.
	Principles of Consolidation
	The Company's consolidated financial statements for the three and six month periods ended December 31, 2013, include the accounts of its two wholly owned subsidiaries, Modern Mobility Aids, Inc. and MDRM Group (Canada) Ltd., both Ontario, Canada based companies. Modern Mobility Aids, Inc. was incorporated on September 2, 2009 and MDRM Group (Canada) Ltd. was incorporated on July 14, 2011. All significant intercompany balances and transactions have been eliminated on consolidation.
	Development Stage Company
	The Company is a development stage company in accordance with Financial Accounting Standards Codification (“ASC”) 915 "Development Stage Entities". Among the disclosures required as a development stage company are that our financial statements are identified as those of a development stage company, and that the statements of operations, stockholders' deficit and cash flows disclose activity since the date of our Inception (December 19, 2007) as a development stage company.
	Cash and Cash Equivalents
	For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.
	Revenue Recognition
	The Company is in the development stage and has realized minimal revenues from operations. The Company recognizes revenues when the sale and/or distribution of products is complete, risk of loss and title to the products have transferred to the customer, there is persuasive evidence of an agreement, acceptance has been approved by its customer, the fee is fixed or determinable based on the completion of stated terms and conditions, and collection of any related receivable is probable. Net revenues are comprised of gross revenues less expected returns, trade discounts, and customer allowances that include costs associated with off-invoice markdowns and other price reductions, as well as trade promotions and coupons. These incentive costs are recognized at the later of the date on which the Company recognized the related revenue or the date on which the Company offers the incentive.
	Loss per Common Share
	Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the periods. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no potentially dilutive debt or equity instruments issued or outstanding during the three and six month periods ended December 31, 2013 and 2012.
	Income Taxes
	The Company accounts for income taxes pursuant to SFAS No. 109, “Accounting for Income Taxes” (“SFAS No. 109”). Under SFAS No. 109, now encompassed under ASC 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.
	The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.
	Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
	Fair Value of Financial Instruments
	The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts Modern Mobility Aids could realize in a current market exchange. As of December 31, 2013, the carrying value of the Company’s financial instruments comprising accounts payable and accruals, due to related parties and loan from shareholders approximated fair value due to the short-term nature and maturity of these instruments.
	Deferred Offering Costs
	The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.
	Impairment of Long-lived Assets
	Capital assets are reviewed for impairment in accordance with SFAS No. 144, “Accounting for the Impairment of Disposal of Long-lived Assets,” which was adopted effective January 1, 2002. Under SFAS No. 144, now encompassed under ASC 350, these assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. An impairment charge is recognized for the amount, if any, which the carrying value of the asset exceeds the fair value. During the three and six month periods ended December 31, 2013, and 2012, the Company did not own any long-lived assets.
	Advertising and Promotion
	The Company expenses all advertising and promotion costs as incurred. The Company did not incur any advertising or promotion costs during the three and six month periods ended December 31, 2013, and 2012.
	Common Stock Registration Expenses
	The Company considers incremental costs and expenses related to the registration of equity securities with the SEC, whether by contractual arrangement as of a certain date or by demand, to be unrelated to original issuance transactions. As such, subsequent registration costs and expenses are reflected in the accompanying financial statements as general and administrative expenses, and are expensed as incurred.
	Stock-Based Compensation
	Stock-based compensation is accounted for at fair value in accordance with ASC 718,”Compensation – Stock Compensation”, when applicable.  To date, the Company has not adopted a stock option plan and has not granted any stock options. As of December 31, 2013 the Company has not issued any stock-based payments to its employees.
	Estimates
	The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
	Reclassifications
	Certain reclassifications have been made to the prior period financial statements to conform to the 2014 presentation. The reclassifications had no effect on net loss, total assets, or total stockholders’ deficit.
	Recently Issued Accounting Pronouncements
	The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of its operations.

Going_Concern

Going Concern	6 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Going Concern	'
	2.             Going Concern
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United State of America, which contemplate continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of December 31, 2013, and June 30, 2013, the Company had a working capital deficit of $(559,635), and $(519,773), respectively. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern.
	The Company has abandoned its historic business of distributing products for mobility challenged individuals which has generated little operating revenue and has had limited operations to date and is now focused on exploiting the dynamic opportunities presented in the medical marijuana arena by the regulatory reforms rolled out in Canada. We plan to acquire or invest in multiple licensed producers in Canada and the U.S. The Company will require financing to make such acquisitions. There can be no assurance it can secure such financing or that it will be able to make such acquisitions even if financing is available. Moreover, even if it acquires business assets or a business, there can be no assurance that the acquisitions will be successfully accomplished and that our operations thereafter will be profitable.
	While management of the Company believes that the Company will be successful in its planned operating activities under its new business plan and capital formation activities, there can be no assurance that it will be successful in implementation of its new business plan or the formation of sufficient capital such that it will generate adequate revenues to earn a profit or sustain its operations.

Due_to_Related_Parties

Due to Related Parties	6 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Due to Related Parties	'
	3.             Due to Related Parties
	In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders.  Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.
	As of December 31, 2013 there was a balance to related parties in the amount of $25,171 for services provided to the Company.
	In November 2013, the Company paid $19,093 to a Company owned by Mr. Karatella for services rendered to and expenses incurred on behalf of the Company during 2011 and 2012 and in November 2013, paid directly to Mr. Karatella $4,773 for services rendered to the Company during 2011 and 2012 for expenses incurred on behalf of the Company.

Shareholder_Loans

Shareholder Loans	6 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Shareholder Loans	'
	4.             Shareholder Loans
	In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders.  Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are considered temporary in nature and have not been formalized by a promissory note.
	As of December 31, 2013, the shareholder loan consisted of $363,275 principal and accrued interest of $Nil. The loan payable is payable on demand, unsecured and bears no interest. The loan shall be payable on demand within five (5) days from the date of request. In the event payment is not timely made, interest will accrue on the unpaid balance at the rate of 15% per annum, compounded monthly, from and after the date of such failure to pay.

Capital_Stock

Capital Stock	6 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Capital Stock	'
	5.             Capital Stock
	The total number of common shares authorized that may be issued by the Company is 200,000,000 shares with a par value of $0.001 per share, and 1,000,000 shares of preferred stock at par value of $0.001 per share.
	Preferred Stock
	No shares of preferred stock were issued and outstanding during the three and six months ended December 31, 2013 and 2012.
	Common Stock
	During the year ended June 30, 2010, the Company issued 130,000,000 (post forward split) shares of common stock at $0.00005 per share to its Directors for total proceeds of $6,500.
	During the year ended June 30, 2011 the Company sold 65,480,000 (post forward split) common shares at $0.000625 per share for total proceeds of $58,767.
	On August 18, 2011, the Company implemented a 20 for 1 forward stock split whereby each shareholder of record received an additional 19 shares of common stock for every 1 share held of record. The total number of common stock issued and outstanding since December 19, 2007 (Inception) have been restated for this forward stock split.
	On November 22, 2013, Mohamed K. Karatella, formerly the Company’s President, Chief Financial Officer, Treasurer, Principal Accounting Officer and the owner of 66.5% of its outstanding common stock agreed to contribute 120,000,000 shares of the Company’s common stock to the Company to be cancelled. Mr. Karatella did not receive any compensation in connection with this transfer. After the transaction, Mr. Karatella owned 10,000,000 shares, 13.25%, of 75,480,000 shares of common stock of the Company then outstanding.
	As at December 31, 2013 there were 75,480,000 shares of common stock issued and outstanding.
	As of December 31, 2013, the Company had not issued any shares nor granted any stock options under share-based compensation transactions.

Income_Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	6.             Income Taxes
	The provision (benefit) for income taxes for the six months ended December 31, 2013 and 2012, were as follows (assuming a 15 percent effective tax rate):
		Six Months Ended
		December 31,
		2013			2012
	Current Tax Provision:
	Federal
	Taxable income	$	-		$	-
	Total current tax provision	$	-		$	-
	Deferred Tax Provision:
	Federal
	Loss carry forwards	$	4,363		$	1,328
	Change in valuation allowance		(4,363	)		(1,328	)
	Total deferred tax provision	$	-		$	-
	The Company had deferred income tax assets as of December 31, 2013 and June 30, 2013 as follows:
		December 31,			June 30,
		2013			2013
	Loss carryforwards	$	624,902		$	585,040
	Less - Valuation allowance		(624,902	)		(585,040	)
	Total net deferred tax assets	$	-		$	-
	As of December 31, 2013, the Company had approximately $624,902 in tax loss carry forwards that can be utilized in future periods to reduce taxable income, and begin to expire in the year 2028.
	The Company provided a valuation allowance equal to the deferred income tax assets for the six months ended December 31, 2013 because it is not presently known whether future taxable income will be sufficient to utilize the loss carry forwards.

Subsequent_Events

Subsequent Events	6 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	7.             Subsequent Events
	The Company has entered into a Memorandum of Understanding and two agreements with two business in its targeted strategy to exploit the dynamic opportunities presented in the medical marijuana arena by the regulatory reforms rolled out in Canada:
	On June 27, 2014 the Company entered into an agreement with DYMA INC., a company incorporated in the Province of Ontario that previously operated a 6000 sq. ft facility under MMAR and is pending a license from Health Canada under MMPR. The Company purchased 308,000 shares of DYMA INC common stock at $0.75 per share representing approximately 14% of the DYMA INC's stock when a current offering is fully subscribed. The highly experienced owners and management of DYMA INC. are actively assisting the MDMR in further assessing and building-out other targeted acquisitions.
	On May 8, 2014, through a wholly-owned subsidiary formed in Ontario, Canada, we entered into an agreement to purchase 100% of a private company in the final stage of obtaining their Medical Marijuana growers license. The company, located in the Province of Ontario, owns a fully functional production facility, and is awaiting final inspection by Health Canada, the federal department responsible for administering the healthcare system in Canada. The transaction includes real property and related facilities. Under the terms of the agreement, the Company will pay CDN$2.5 million at Closing with an additional CDN$2.5 million due at a deferred date. The Company will also issue a warrant to the sellers to purchase up to 1 million shares of the Company shares at a 25% discount to market. The closing of the purchase is subject to receipt of a license from Health Canada under MMPR.
	On March 28, 2014, through a wholly-owned subsidiary incorporated under the laws of Ontario, Canada, we entered into a Memorandum of Understanding to purchase 67% of a private company with a pending application for a license from Health Canada under the recently enacted Marijuana for Medical Purposes Regulation (“MMPR”). The facilities are located in the Province of Ontario. In addition, the agreement provides that we will also acquire a 50% interest in a related private corporation which has received a “ready to build” letter from Health Canada in conjunction with a pending application for a license to conduct research on marijuana. The closing of this transaction is contingent on the issuance of the respective licenses by Health Canada.
	The Company is actively and aggressively pursuing various other opportunities within the medical marijuana sector. To this end, we have entered into letters of intent to purchase controlling interests in two other private companies each in the final stages of obtaining their Medical Marijuana growers license. The actual terms and conditions of these two proposed transactions will be disclosed at such time as the Company has entered into definitive agreements on the matters.
	In accordance with ASC 855, Subsequent Events, the Company has evaluated events that occurred subsequent to the balance sheet date through July 9, 2014 the date of available issuance of these unaudited financial statements. The Company determined that other than as disclosed above, there were no material reportable subsequent events to be disclosed.

Nature_of_Operations_and_Summa1

Nature of Operations and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Basis of Presentation and Organization	'
	Basis of Presentation and Organization
	Modern Mobility Aids, Inc. (the “Company,” “we,” “us” or “our”) is a Nevada corporation in the development stage. The Company was incorporated under the laws of the State of Nevada on December 19, 2007 (“Inception”) under the name Glider Inc. with a business plan to sell and distribute products for mobility challenged individuals. The Company changed its name to Modern Mobility Aids, Inc. on April 22, 2010 with an initial plan to distribute products for mobility challenged individuals.
	The Company has abandoned its historic business of distributing products for mobility challenged individuals which has generated little operating revenue and has had limited operations to date and is now focused on exploiting the dynamic opportunities presented in the medical marijuana arena by the regulatory reforms rolled out in Canada. We plan to acquire or invest in multiple licensed producers in Canada and the U.S. The Company will require financing to make such acquisitions. There can be no assurance it can secure such financing or that it will be able to make such acquisitions even if financing is available. Moreover, even if it acquires business assets or a business, there can be no assurance that the acquisitions will be successfully accomplished and that our operations thereafter will be profitable.
Unaudited Financial Statements	'
	Unaudited Financial Statements
	The accompanying unaudited financial statements of the Company have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion the financial statements include all adjustments (consisting of normal recurring accruals) necessary in order to make the financial statements not misleading. Operating results for the three and six month periods ended December 31, 2013 are not necessarily indicative of the results that may be expected for the year ended June 30, 2014. For more complete financial information, these unaudited financial statements should be read in conjunction with the audited financial statements for the year ended June 30, 2013 included in our Form 10-K filed with the SEC.
Principles of Consolidation	'
	Principles of Consolidation
	The Company's consolidated financial statements for the three and six month periods ended December 31, 2013, include the accounts of its two wholly owned subsidiaries, Modern Mobility Aids, Inc. and MDRM Group (Canada) Ltd., both Ontario, Canada based companies. Modern Mobility Aids, Inc. was incorporated on September 2, 2009 and MDRM Group (Canada) Ltd. was incorporated on July 14, 2011. All significant intercompany balances and transactions have been eliminated on consolidation.
Development Stage Company	'
	Development Stage Company
	The Company is a development stage company in accordance with Financial Accounting Standards Codification (“ASC”) 915 "Development Stage Entities". Among the disclosures required as a development stage company are that our financial statements are identified as those of a development stage company, and that the statements of operations, stockholders' deficit and cash flows disclose activity since the date of our Inception (December 19, 2007) as a development stage company.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.
Revenue Recognition	'
	Revenue Recognition
	The Company is in the development stage and has realized minimal revenues from operations. The Company recognizes revenues when the sale and/or distribution of products is complete, risk of loss and title to the products have transferred to the customer, there is persuasive evidence of an agreement, acceptance has been approved by its customer, the fee is fixed or determinable based on the completion of stated terms and conditions, and collection of any related receivable is probable. Net revenues are comprised of gross revenues less expected returns, trade discounts, and customer allowances that include costs associated with off-invoice markdowns and other price reductions, as well as trade promotions and coupons. These incentive costs are recognized at the later of the date on which the Company recognized the related revenue or the date on which the Company offers the incentive.
Loss per Common Share	'
	Loss per Common Share
	Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the periods. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no potentially dilutive debt or equity instruments issued or outstanding during the three and six month periods ended December 31, 2013 and 2012.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes pursuant to SFAS No. 109, “Accounting for Income Taxes” (“SFAS No. 109”). Under SFAS No. 109, now encompassed under ASC 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.
	The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.
	Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts Modern Mobility Aids could realize in a current market exchange. As of December 31, 2013, the carrying value of the Company’s financial instruments comprising accounts payable and accruals, due to related parties and loan from shareholders approximated fair value due to the short-term nature and maturity of these instruments.
Deferred Offering Costs	'
	Deferred Offering Costs
	The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.
Impairment of Long-lived Assets	'
	Impairment of Long-lived Assets
	Capital assets are reviewed for impairment in accordance with SFAS No. 144, “Accounting for the Impairment of Disposal of Long-lived Assets,” which was adopted effective January 1, 2002. Under SFAS No. 144, now encompassed under ASC 350, these assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. An impairment charge is recognized for the amount, if any, which the carrying value of the asset exceeds the fair value. During the three and six month periods ended December 31, 2013, and 2012, the Company did not own any long-lived assets.
Advertising and Promotion	'
	Advertising and Promotion
	The Company expenses all advertising and promotion costs as incurred. The Company did not incur any advertising or promotion costs during the three and six month periods ended December 31, 2013, and 2012.
Common Stock Registration Expenses	'
	Common Stock Registration Expenses
	The Company considers incremental costs and expenses related to the registration of equity securities with the SEC, whether by contractual arrangement as of a certain date or by demand, to be unrelated to original issuance transactions. As such, subsequent registration costs and expenses are reflected in the accompanying financial statements as general and administrative expenses, and are expensed as incurred.
Stock-based Compensation	'
	Stock-Based Compensation
	Stock-based compensation is accounted for at fair value in accordance with ASC 718,”Compensation – Stock Compensation”, when applicable.  To date, the Company has not adopted a stock option plan and has not granted any stock options. As of December 31, 2013 the Company has not issued any stock-based payments to its employees.
Estimates	'
	Estimates
	The accompanying financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from these estimates.
Reclassifications	'
	Reclassifications
	Certain reclassifications have been made to the prior period financial statements to conform to the 2014 presentation. The reclassifications had no effect on net loss, total assets, or total stockholders’ deficit.
Recently Adopted Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of its operations.

Income_Taxes_Tables

Income Taxes (Tables)	6 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Provision (benefit) for income taxes	'
		Six Months Ended
		December 31,
		2013			2012
	Current Tax Provision:
	Federal
	Taxable income	$	-		$	-
	Total current tax provision	$	-		$	-
	Deferred Tax Provision:
	Federal
	Loss carry forwards	$	4,363		$	1,328
	Change in valuation allowance		(4,363	)		(1,328	)
	Total deferred tax provision	$	-		$	-
Deferred income tax assets	'
		December 31,			June 30,
		2013			2013
	Loss carryforwards	$	624,902		$	585,040
	Less - Valuation allowance		(624,902	)		(585,040	)
	Total net deferred tax assets	$	-		$	-

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	6 Months Ended	12 Months Ended
	Dec. 31, 2013	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'	'
Working Shareholders deficiency	($559,635)	($519,773)

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	Dec. 31, 2013	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
Related Party Transactions [Abstract]	'	'	'	'
Due to related parties	$25,171	$19,179	'	'
Payment to company owned by Mr. Karatella	'	19,093	'	'
Payment to Mr. Karatella	'	'	$4,773	$4,773

Shareholder_Loans_Details_Narr

Shareholder Loans (Details Narrative) (Shareholder [Member], USD $)	6 Months Ended
	Dec. 31, 2013
Shareholder [Member]	'
Short-term Debt	$363,275
Interest Payable	$0
Short-term debt, interest rate	15.00%
Short-term Debt, Terms	'
	The loan shall be payable on demand within five (5) days from the date of request

Capital_Stock_Details_Narrativ

Capital Stock (Details Narrative) (USD $)	12 Months Ended	69 Months Ended			12 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2012	Sep. 30, 2013	Dec. 31, 2013	Jun. 30, 2013	Jun. 30, 2010	Dec. 31, 2013		Jun. 30, 2011
					Director [Member]	Cheif Financial Officer [Member]		Common Stock [Member]
Common stock, shares authorized	'	'	200,000,000	200,000,000	'	'		'
Common stock, par value	'	'	$0.00	$0.00	'	'		'
Common stock, shares outstanding	'	'	75,480,000	195,480,000	'	'		'
Preferred stock, shares authorized	'	'	1,000,000	1,000,000	'	'		'
Preferred stock, par value	'	'	$0.00	$0.00	'	'		'
Common stock shares new issued	'	195,480,000	'	'	130,000,000	'		65,480,000
Share Price	'	'	'	'	$0.00	'		$0.00
Common stock value new issued	'	'	'	'	$6,500	'		$58,767
Stockholders' Equity Note, Stock Split	'20:1	'	'	'	'	'		'
Ownership	'	'	'	'	'	66.50%		'
Cancellation of Shares	'	'	'	'	'	120,000,000		'
Shares held by Officer	'	'	'	'	'	10,000,000	[1]	'
New Ownership percentage	'	'	'	'	'	13.00%		'
[1]	of 75,480,000 shares of common stock of the Company then outstanding

Income_Taxes_Provision_benefit

Income Taxes - Provision (benefit) for income taxes (Details) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred Tax Provision:	'	'
Loss carryforwards	$4,363	$1,328
Change in valuation allowance	-4,363	-1,328
Total deferred tax provision	'	'

Income_Taxes_Deferred_income_t

Income Taxes - Deferred income tax assets (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'	'
Loss carryforwards	$624,902	$585,040
Less - Valuation allowance	-624,902	-585,040
Total net deferred tax assets	'	'

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'
Effective tax rate	15.00%	15.00%	'
Loss carryforwards	$624,902	'	$585,040

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2013
	Subsequent Event 1 [Member]	Subsequent Event 2 [Member]
	USD ($)	CAD
Entity acquired	14.00%	67.00%
Shares purchased	308,000	'
Share price	$0.75	'
Purchase acquisition price	'	2,500,000
Subsequent payment	'	2,500,000
Warrant issued	'	1,000,000
Discount to market	'	25.00%